Tarsus Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

Tarsus Pharmaceuticals, Inc.

Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phas…

Biotechnology
US, Irvine [HQ]
Revenue Breakdowns

Segment Analysis Beta

The financial segments are sourced from the SEC' 10-K statement.

Revenue By Top Segments

Tarsus Pharmaceuticals, Inc. can't present it's sankey chart.

Historical Revenue By Segment

Last 3Y, in million USD

Tarsus Pharmaceuticals, Inc. can't present revenue by segment

Get PRO Today

With PRO you can bypass the blur for the segment revenues of Tarsus Pharmaceuticals, Inc..

If you want to see a demo, head over to the financial segments of AAPL

End of TARS's Analysis
CIK: 1819790 CUSIP: 87650L103 ISIN: US87650L1035 LEI: - UEI: -
Secondary Listings
TARS has no secondary listings inside our databases.